Appointment booking for Dr. Antonio Ambrad, MD is currently not available.Dr. Antonio Ambrad, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Antonio Ambrad, MD (he/him) is a Radiologist in Pittsburgh, PA with over 19 years of experience. What is your opinion of Dr. Antonio Ambrad, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Antonio Ambrad, MD has received over $719 which includes payments from the following companies:
$99.95 from Janssen Products, LP
$73.54 from Incyte Corporation
$70.67 from Eisai Inc.
$67.00 from Janssen Biotech, Inc.
$56.31 from Amgen Inc.
$47.11 from E.R. Squibb & Sons, L.L.C.
$43.62 from INSYS Therapeutics Inc
$35.49 from Novartis Pharmaceuticals Corporation
$35.13 from Astellas Pharma US Inc
$30.75 from Daiichi Sankyo Inc.
$24.00 from Boehringer Ingelheim Pharmaceuticals, Inc.
$16.98 from Celgene Corporation
$16.01 from Rigel Pharmaceuticals, Inc.
$15.91 from Medivation Inc.
$13.92 from Seattle Genetics, Inc.
$12.93 from LILLY USA, LLC
$12.89 from TESARO, Inc.
$12.44 from Foundation Medicine, Inc.
$12.29 from AstraZeneca Pharmaceuticals LP
$11.69 from Ipsen Biopharmaceuticals, Inc
Payments received by Dr. Antonio Ambrad, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!